Applications

1379 – IncobotulinumtoxinA (XEOMIN), injection of, for blepharospasm, cervical dystonia (spasmodic torticollis) and post-stroke spasticity of the upper limb

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type -
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome -

Application details

Reason for application

New MBS item.

Service or technology in this application

IncobotulinumtoxinA for blepharospasm, cervical dystonia (spasmodic torticollis) and post-stroke spasticity of the upper limb.

Type: Therapeutic

Medical condition this application addresses

Blepharospasm is a chronic progressive disorder, defined as involuntary, sporadic or permanent eyelid closure resulting in significant visual disability.

Cervical dystonia (spasmodic torticollis) covers a spectrum of involuntary movements with abnormal posture of the head and shoulder/neck region.

Post-stroke spasticity of the upper limb imposes a considerable humanistic burden. It is not only painful, but is often associated with functional impairment in personal hygiene and dressing, necessitating the help of a family member or professional caregiver.

Application documents

Meetings to consider this application

  • PASC meeting: Not required.
  • ESC meeting: Not required.
  • MSAC meeting: 3 October 2014